- Bladder cancer, in combination with cisplatin
- Ovarian cancer, in combination with carboplatin
- Breast cancer, in combination with paclitaxel
- Pancreatic cancer
- Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin


GEMTERO 200MG
MRP | : |
|
Price | : | ₹700.00 |
You Save | : | ₹688.20 (49.57%) |
1 Vial(s)
Gemtero 200mg injection is a chemotherapy drug that contains gemcitabine as its active ingredient. It is utilized in the treatment of various cancers, including bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is characterized by the uncontrolled and abnormal proliferation of cells. Consult your physician if you have a history of heart disease, liver issues, kidney problems, have recently undergone radiotherapy, or have been vaccinated prior to using this medication.
Gemtero 200mg injection is not advised for adolescents and children under 18 years of age. Your healthcare provider will evaluate your blood cell counts along with kidney and liver function each time you receive this treatment. It is essential to use effective contraception during the course of treatment and for at least six months following the final dose. This injection may affect fertility in male patients. Men receiving this medication are cautioned against fathering a child during treatment and for six months afterward.
Inform your doctor if you are following a salt-restricted diet, as this medication contains sodium. Notify your physician immediately if you experience symptoms such as shortness of breath, wheezing, changes in urine color or volume, bleeding, or upper abdominal pain while receiving Gemtero 200mg injection.